INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Cryogenic Storage Of IV Bags For Cell And Gene Therapies

  Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.

• How To Save Significantly On Early-Phase Clinical Supply

  Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

• Pharmaceutical Supply Chain Management Best Practices

  Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

• Supply Chain Efficiency And Sourcing In Gene Therapy

  An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  6/9/2025

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics

  5/29/2025

  Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.

• The Importance Of Quality In Raw Material Selection

  1/16/2025

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

• Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges

  8/21/2024

  Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  2/11/2026

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.